Webinar Date/Time: Fri, Mar 21, 2025 11:00 AM EDT
Find out more about the key drivers that are shaping the bio/pharma outsourcing market. Additionally, learn about the benefits of integrated services and potential trends that will impact the outsourcing sector in the near future.
Register Free: https://www.pharmtech.com/pt_w/strategic-partnerships
Event Overview:
In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about strategic partnerships in the bio/pharma industry. During the discussion, various experts will detail how the bio/pharma outsourcing market has evolved, how service providers have adapted to meet the shifting industry demands, the benefit of ‘integrated services’ and the potential challenge to providing such services while also being flexible, and potential trends that may shape the outsourcing market in the coming years.
Interviews featuring:
This episode of Drug Digest is sponsored by:
Key Learning Objectives:
Who Should Attend:
Speaker:
John McQuaid
President and Managing Director
Almac Pharma Services
John first joined Almac Group in 1994 and has held a number of management roles during his tenure. In 2011 he was appointed to Vice President of Technical Operations within Almac Pharma Services where he was responsible for overseeing the strategic growth and development of the Pharmaceutical Development & Manufacturing service offering.
John, who holds a BSc Honours degree, was promoted to President and Managing Director, Almac Pharma Services, in 2022 and is responsible for the strategic, financial and operational leadership of global business. He has extensive product development, quality assurance and validation experience with direct experience of hosting product pre-approval inspections by multiple regulatory authorities.
Register Free: https://www.pharmtech.com/pt_w/strategic-partnerships
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.